Aeria Inc. (TYO:3758)

Intra-Cellular Therapies Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8,384	8,249	8,764	9,456	9,717	8,339
Short-Term Investments	47	66	81	400	350	410
Cash & Short-Term Investments	8,431	8,315	8,845	9,856	10,067	8,749
Cash Growth	-1.31%	-5.99%	-10.26%	-2.10%	15.07%	-14.35%
Accounts Receivable	1,410	1,686	2,323	1,856	2,199	2,620
Other Receivables	4	4	361	266	33	183
Receivables	1,414	1,690	2,684	2,122	2,232	2,803
Inventory	5,207	5,018	5,265	4,680	3,122	3,451
Prepaid Expenses	302	235	552	602	362	308
Other Current Assets	982	762	1,651	813	472	415
Total Current Assets	16,336	16,020	18,997	18,073	16,255	15,726
Property, Plant & Equipment	2,578	2,690	287	309	301	334
Long-Term Investments	1,479	1,398	1,397	1,300	1,478	1,691
Goodwill	-	-	162	292	514	932
Other Intangible Assets	90	88	196	351	299	235
Long-Term Deferred Tax Assets	54	57	98	36	168	243
Other Long-Term Assets	1	3	1	1	1	3
Total Assets	20,545	20,263	21,145	20,369	19,243	19,392
Accounts Payable	537	577	724	719	820	799
Accrued Expenses	279	274	219	276	340	335
Short-Term Debt	1,028	928	1,795	994	840	719
Current Portion of Long-Term Debt	2,337	2,125	1,813	1,863	1,326	1,462
Current Income Taxes Payable	294	522	467	418	383	411
Other Current Liabilities	2,592	2,376	2,527	3,443	3,186	3,110
Total Current Liabilities	7,067	6,802	7,545	7,713	6,895	6,836
Long-Term Debt	4,323	4,393	3,405	2,940	2,746	3,282
Long-Term Deferred Tax Liabilities	274	257	198	122	95	23
Other Long-Term Liabilities	184	186	263	244	289	317
Total Liabilities	11,894	11,684	11,465	11,079	10,091	10,563
Common Stock	100	100	100	100	100	100
Additional Paid-In Capital	9,313	9,419	9,580	9,739	9,795	9,918
Retained Earnings	212	22	762	281	260	-326
Treasury Stock	-1,400	-1,322	-1,102	-1,190	-1,279	-1,191
Comprehensive Income & Other	245	173	185	210	142	76
Total Common Equity	8,470	8,392	9,525	9,140	9,018	8,577
Minority Interest	181	187	155	150	134	252
Shareholders' Equity	8,651	8,579	9,680	9,290	9,152	8,829
Total Liabilities & Equity	20,545	20,263	21,145	20,369	19,243	19,392
Total Debt	7,688	7,446	7,013	5,797	4,912	5,463
Net Cash (Debt)	743	869	1,832	4,059	5,155	3,286
Net Cash Growth	-70.82%	-52.57%	-54.87%	-21.26%	56.88%	-15.46%
Net Cash Per Share	34.26	39.49	82.41	183.51	233.76	144.03
Filing Date Shares Outstanding	20.88	20.91	22.27	22.16	22.05	21.97
Total Common Shares Outstanding	20.88	21.2	22.27	22.16	22.05	22.27
Working Capital	9,269	9,218	11,452	10,360	9,360	8,890
Book Value Per Share	405.60	395.94	427.64	412.41	408.95	385.20
Tangible Book Value	8,380	8,304	9,167	8,497	8,205	7,410
Tangible Book Value Per Share	401.29	391.79	411.57	383.40	372.08	332.79

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.